l carnitine for hyperammonemia Acute pediatric hyperammonemia: current diagnosis and management strategies Carnitine Synergy (D) – Mark

Moving forward, well-designed clinical trials, standardized protocols for strain selection and dosage, and regulatory harmonization will be essential for translating laboratory findings into effective interventions

Collectively, there are inconsistent findings supporting the clinical use of vitamins E, A, and D in delaying or preventing the progression or onset of prostate cancer, and most of the studies are limited in their duration of exposure and sample size

How light exposure can increase peptide degradation risk, and why light protection is part of a broader storage-control strategy rather than a single magic fix

Neuroscience 111 , 814835 (2002)

Correction for: suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin